Jan Medina | Investor Relations |
Spiro Rombotis | President and Chief Executive Officer |
Paul McBarron | Executive Vice President, Finance & Chief Operating Officer |
Judy Chiao | Vice President of Clinical Development & Regulatory Affairs |
Jonathan Aschoff | ROTH Capital Partners |
Kumar Raja | Brooklyn Capital Markets |
Wangzhi Li | Ladenburg |
Good afternoon, and welcome to the Cyclacel Pharmaceuticals Second Quarter 2020 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. After today's call, members of the financial community will have an opportunity to ask questions. [Operator Instructions] The Company will also be accepting a limited number of questions submitted via email to the address IR@cyclacel.com. [Operator Instructions] Please note that today's call is being recorded.